Abivax SA (France) Probability of Future Stock Price Finishing Over 8.58
| ABVX Stock | EUR 8.44 0.24 2.93% |
Abivax |
Abivax SA Target Price Odds to finish over 8.58
The tendency of Abivax Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over € 8.58 or more in 90 days |
| 8.44 | 90 days | 8.58 | about 90.44 |
Based on a normal probability distribution, the odds of Abivax SA to move over € 8.58 or more in 90 days from now is about 90.44 (This Abivax SA probability density function shows the probability of Abivax Stock to fall within a particular range of prices over 90 days) . Probability of Abivax SA price to stay between its current price of € 8.44 and € 8.58 at the end of the 90-day period is roughly 2.43 .
Assuming the 90 days trading horizon Abivax SA has a beta of 0.99. This suggests Abivax SA market returns are sensitive to returns on the market. As the market goes up or down, Abivax SA is expected to follow. Additionally Abivax SA has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Abivax SA Price Density |
| Price |
Predictive Modules for Abivax SA
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Abivax SA. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Abivax SA Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Abivax SA is not an exception. The market had few large corrections towards the Abivax SA's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Abivax SA, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Abivax SA within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.41 | |
β | Beta against Dow Jones | 0.99 | |
σ | Overall volatility | 0.88 | |
Ir | Information ratio | -0.16 |
Abivax SA Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Abivax SA for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Abivax SA can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Abivax SA generated a negative expected return over the last 90 days | |
| The company reported the revenue of 37 K. Net Loss for the year was (41.36 M) with loss before overhead, payroll, taxes, and interest of (45.52 M). | |
| Abivax SA has accumulated about 6 K in cash with (45.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.28. |
Abivax SA Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Abivax Stock often depends not only on the future outlook of the current and potential Abivax SA's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Abivax SA's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 12.2 M | |
| Cash And Short Term Investments | 60.7 M |
Abivax SA Technical Analysis
Abivax SA's future price can be derived by breaking down and analyzing its technical indicators over time. Abivax Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Abivax SA. In general, you should focus on analyzing Abivax Stock price patterns and their correlations with different microeconomic environments and drivers.
Abivax SA Predictive Forecast Models
Abivax SA's time-series forecasting models is one of many Abivax SA's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Abivax SA's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Abivax SA
Checking the ongoing alerts about Abivax SA for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Abivax SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Abivax SA generated a negative expected return over the last 90 days | |
| The company reported the revenue of 37 K. Net Loss for the year was (41.36 M) with loss before overhead, payroll, taxes, and interest of (45.52 M). | |
| Abivax SA has accumulated about 6 K in cash with (45.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.28. |
Other Information on Investing in Abivax Stock
Abivax SA financial ratios help investors to determine whether Abivax Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Abivax with respect to the benefits of owning Abivax SA security.